• Home
  • About Us
    Overview
    Prize
    Management Team
    Major Subsidiaries
  • Business
    Pharmaceutical
    Fitness
  • Investor Relations
    Company Information
    Announcements and Circulars
    Financial and Other Reports
    Corporate Governance
    Arrangements on Dissemination of Corporate Communications
    IR Enquiries
  • Contact Us
  • 繁
  • 简

2025
  • 2025
    1. 2025
    2. 2024
    3. 2023
    4. 2022
    5. 2021
    6. 2020
    7. 2019
    8. 2018
    9. 2017
    10. 2016
    11. 2015
    12. 2014
    13. 2013
    14. 2012
    15. 2011
  • 2025.05.07
    Monthly ReturnsMonthly Return of Equity Issuer on Movements in Securities for the month ended 30th April, 2025
  • 2025.04.29
    Circulars - [Other]NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM - NOTIFICATION OF PUBLICATION OF 2024 ANNUAL REPORT, CIRCULAR DATED 30 APRIL 2025, NOTICE OF ANNUAL GENERAL MEETING AND PROXY FORM
  • 2025.04.29
    Circulars - [Other]NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM - NOTICE OF PUBLICATION OF 2024 ANNUAL REPORT, CIRCULAR DATED 30 APRIL 2025, NOTICE OF ANNUAL GENERAL MEETING AND PROXY FORM
  • 2025.04.29
    Proxy FormsAnnual General Meeting Form of Proxy
  • 2025.04.29
    Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period]NOTICE OF ANNUAL GENERAL MEETING
  • 2025.04.29
    Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director subject to Shareholders' Approval]PROPOSALS FOR RE-ELECTION OF DIRECTORS, GENERAL MANDATES TO ISSUE SECURITIES AND BUY BACK SHARES AND NOTICE OF ANNUAL GENERAL MEETING
  • 2025.04.25
    Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period]RESCHEDULING OF ANNUAL GENERAL MEETING AND CHANGE OF BOOK CLOSURE PERIOD
  • 2025.04.08
    Monthly ReturnsMonthly Return of Equity Issuer on Movements in Securities for the month ended 31st March, 2025
  • 2025.03.28
    Announcements and Notices - [Final Results / Closure of Books or Change of Book Closure Period]ANNOUNCEMENT OF AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024
  • 2025.03.17
    Announcements and Notices - [Date of Board Meeting]DATE OF BOARD MEETING
  • 2025.03.11
    Announcements and Notices - [Profit Warning / Inside Information]PROFIT WARNING
  • 2025.03.05
    Monthly ReturnsMonthly Return of Equity Issuer on Movements in Securities for the month ended 28th February, 2025
  • 2025.02.05
    Monthly ReturnsMonthly Return of Equity Issuer on Movements in Securities for the month ended 31st January, 2025
  • 2025.01.07
    Announcements and Notices - [Continuing Connected Transaction]SUPPLEMENTAL ANNOUNCEMENT FOR CONTINUING CONNECTED TRANSACTIONS IN RELATION TO MASTER TENANCY AGREEMENT
  • 2025.01.03
    Monthly ReturnsMonthly Return of Equity Issuer on Movements in Securities for the month ended 31st December, 2024
  • About Us
    Overview Prize Management Team Major Subsidiaries
  • Business
    Pharmaceutical Fitness
  • Investor Relations
    Company Information Announcements and Circulars Financial and Other Reports Corporate Governance Arrangements on Dissemination of Corporate Communications IR Enquiries
  • Contact Us
  • © Kontafarma China Holdings Limited.
    All Rights Reserved. | Disclaimer